Clozapine prolongs hypotonic immobility in rats with bilateral 6-hydroxydopamine lesions of the striatum

被引:0
|
作者
Jaskiw, GE
Hussain, G
Stephans, SE
Yamamoto, BK
Meltzer, HY
机构
[1] Louis Stokes Cleveland VAMC, Psychiat Serv 116AB, Brecksville, OH 44141 USA
[2] Case Western Reserve Univ, Dept Psychiat, Cleveland, OH 44106 USA
[3] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[4] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02215 USA
[5] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA
[6] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA
关键词
hatoperidol; dopamine; antipsychotic; extrapyramidal symptoms;
D O I
10.1016/j.neulet.2004.01.079
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Clozapine does not induce classical catalepsy. One explanation is that endogenous dopamine (DA) readily displaces clozapine from postsynaptic striatal DA receptors. If the latter were true, then depletion of striatal DA should permit clozapine to induce classical catalepsy. Rats received bilateral sham or 6-hydroxydopamine (6-OHDA) lesions of the striatum. Catalepsy using the bar test was assessed on days 21, 28 and 35 after i.p. vehicle, haloperidol (0.75 mg/kg) or clozapine (20 mg/kg). Brains were harvested on day 36 and striatal DA was assayed. A 97% depletion of striatal DA was associated with a significant increase in the duration of immobility after haloperidol or clozapine administration. Both in sham as well as in 6-OHDA lesioned animals, however, the duration of immobility was greater after haloperidol than after clozapine. Furthermore, clozapine-treated animals were hypotonic and did not show the classic rigidity of haloperidol catalepsy. While clozapine's low propensity to induce immobility in animals and extrapyramidal symptoms in man may depend in part on endogenous striatal DA, other mechanisms must also be involved. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 50 条
  • [31] Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions
    Zhang, KH
    Davids, E
    Tarazi, FI
    Baldessarini, RJ
    PSYCHOPHARMACOLOGY, 2002, 161 (01) : 100 - 106
  • [32] Rapid increase of Nurr1 expression in the Substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat
    Ojeda, V
    Fuentealba, JA
    Galleguillos, D
    Andrés, ME
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (05) : 686 - 697
  • [33] Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine
    S. Dethy
    M. A. Laute
    P. Damhaut
    S. Goldman
    Journal of Neural Transmission, 1999, 106 : 145 - 158
  • [34] Pergolide potentiates L-DOPA-induced dopamine release in rat striatum after lesioning with 6-hydroxydopamine
    Dethy, S
    Laute, MA
    Damhaut, P
    Goldman, S
    JOURNAL OF NEURAL TRANSMISSION, 1999, 106 (02) : 145 - 158
  • [35] Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum
    Opacka-Juffry, J
    Wilson, AW
    Blunt, SB
    BRAIN RESEARCH, 1998, 810 (1-2) : 27 - 33
  • [36] Time course of deficits in open field behavior after unilateral neostriatal 6-hydroxydopamine lesions
    Jaime Fornaguera
    Rainer K. W. Schwarting
    Neurotoxicity Research, 2002, 4 : 41 - 49
  • [37] 6-Hydroxydopamine Lesions in the Rat Neostriatum Impair Sequential Learning in a Serial Reaction Time Task
    Moritz Thede Eckart
    Moriah Christina Huelse-Matia
    Rebecca S. McDonald
    Rainer K.-W. Schwarting
    Neurotoxicity Research, 2010, 17 : 287 - 298
  • [38] In vivo extracellular recording of striatal neurons in the awake rat following unilateral 6-hydroxydopamine lesions
    Chen, MT
    Morales, M
    Woodward, DJ
    Hoffer, BJ
    Janak, PH
    EXPERIMENTAL NEUROLOGY, 2001, 171 (01) : 72 - 83
  • [39] Time Course of Deficits in Open Field Behavior After Unilateral Neostriatal 6-hydroxydopamine Lesions
    Fornaguera, Jaime
    Schwarting, Rainer K. W.
    NEUROTOXICITY RESEARCH, 2002, 4 (01) : 41 - 49
  • [40] 6-HYDROXYDOPAMINE LESIONS OF THE OLFACTORY TUBERCLE DO NOT ALTER (+)-AMPHETAMINE-CONDITIONED PLACE PREFERENCE
    CLARKE, PBS
    WHITE, NM
    FRANKLIN, KBJ
    BEHAVIOURAL BRAIN RESEARCH, 1990, 36 (1-2) : 185 - 188